1548P A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma

Autor:	Mrinal M. Gounder, Patricia LoRusso, Scott A. Laurie, A. Perez-Pitarch, Junxian Geng, N. Yamamoto, M. Lahmar, Manish R. Patel, Todd M. Bauer, J. Cheng
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Dose escalation Antagonist Mdm2 p53 In patient Hematology Metastatic sarcoma business
Zdroj:	Annals of Oncology. 32:S1124-S1125
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.878
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4e333b2c5f25bf814f32e1b3cb8a6568 https://doi.org/10.1016/j.annonc.2021.08.878 Zobrazit plný text záznamu